Work

Supplementary Data from p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Data from p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition

DOI: 10.1158/1535-7163.22523211

Authors: Felix Oppel, Senyao Shao, Sarah Gendreizig, Mark W. Zimmerman, Matthias Schürmann, Viyof Ful Flavian, Peter Goon, Susan N. Chi, Jon C. Aster, Holger Sudhoff, A. Thomas Look

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362530015

Cites: 2

Cited by:

Related to: 10